🔎 Trials Near Me

Utama › Kanser Prostat › Kansas

Kajian klinikal Kanser Prostat di Kansas

22 kajian untuk Kanser Prostat sedang mencari peserta di lokasi di Kansas.

Bandar di Kansas

Teks kajian rasmi (Bahasa Inggeris)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • HaysMed, Hays
  • Lawrence Memorial Hospital, Lawrence
  • The University of Kansas Cancer Center - Olathe, Olathe
  • dan 4 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 2 Okt 2026 · NCT06931340

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Central Care Cancer Center - Garden City, Garden City
  • Central Care Cancer Center - Great Bend, Great Bend
  • Veteran Administration Eastern Kansas Healthcare, Leavenworth
  • dan 4 lagi
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • University of Kansas Cancer Center, Kansas City
  • The University of Kansas Cancer Center - Olathe, Olathe
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • dan 2 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06632977

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • HaysMed, Hays
  • Lawrence Memorial Hospital, Lawrence
  • The University of Kansas Cancer Center - Olathe, Olathe
  • dan 4 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT03866382

DESTINY-PANTUMOUR04

  • Research Site, Topeka
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 130 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07124000

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • University of Kansas Hospital, Kansas City
Mengambil pesertaFasa 2/3
Umur 18 hingga 100 · Lelaki · Dikemas kini 22 Sep 2026 · NCT06780670

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • University of Kansas Medical Center, Westwood
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 22 Sep 2026 · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • University of Kansas Hospital, Kansas City
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Lelaki · Dikemas kini 22 Sep 2026 · NCT06855277

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

  • University of Kansas Medical Center, Kansas City
Mengambil pesertaFasa 1
Umur 18 ke atas · Lelaki · Dikemas kini 15 Sep 2026 · NCT07581184

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • Wichita Urology Group, Wichita
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 11 Sep 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • University of Kansas Cancer Center, Kansas City
  • Lawrence Memorial Hospital, Lawrence
  • The University of Kansas Cancer Center - Olathe, Olathe
  • dan 3 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 10 Sep 2026 · NCT05946213

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

  • Kansas University Cancer Center, Kansas City
Mengambil pesertaFasa 2
Umur 18 ke atas · Lelaki · Dikemas kini 24 Ogo 2026 · NCT07745361

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

  • MidAmerica Cancer Care, Merriam
Mengambil pesertaFasa 1
Umur 18 ke atas · Lelaki · Dikemas kini 21 Ogo 2026 · NCT04221542

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Central Care Cancer Center - Garden City, Garden City
  • Mercy Hospital Pittsburg, Pittsburg
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 19 Ogo 2026 · NCT04423211

HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer

  • University of Kansas Health System, Kansas City
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT03802851

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Instititute - South, Overland Park
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 19 hingga 110 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT02012699

TERPS Trial for de Novo Oligometastic Prostate Cancer

  • KU Medical Center- Cancer Center, Kansas City
Mengambil pesertaFasa 2
Umur 18 ke atas · Lelaki · Dikemas kini 3 Jun 2026 · NCT05223803

Study of AZD0754 in Participants With Metastatic Prostate Cancer

  • Research Site, Westwood
Mengambil pesertaFasa 1/2
Umur 18 hingga 130 · Lelaki · Dikemas kini 23 Feb 2026 · NCT06267729

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

  • Wichita Urology Group, Wichita
Mengambil pesertaFasa 1
Umur 18 ke atas · Lelaki · Dikemas kini 4 Feb 2026 · NCT04729114

Vitamin D for Prostate Endocrine Therapy

  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Health System Saint Francis Campus, Topeka
  • dan 1 lagi
Mengambil pesertaFasa 3
Umur 50 ke atas · Lelaki · Dikemas kini 15 Jan 2026 · NCT05838716

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • University of Kansas Cancer Center, Kansas City
  • Olathe Health Cancer Center, Olathe
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 11 Sep 2025 · NCT03678025

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.